PlainRecalls
FDA Drug Moderate Class II Terminated

Morphine Sulfate, 20 mg/mL intrathecal, 20 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901

Reported: March 18, 2020 Initiated: February 24, 2020 #D-1007-2020

Product Description

Morphine Sulfate, 20 mg/mL intrathecal, 20 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901

Reason for Recall

Lack Of Processing Controls

Details

Units Affected
1 20 ml syringe
Distribution
Sold to patients in Nebraska
Location
Hastings, NE

Frequently Asked Questions

What product was recalled?
Morphine Sulfate, 20 mg/mL intrathecal, 20 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901. Recalled by Redline Pharmacy Solutions. Units affected: 1 20 ml syringe.
Why was this product recalled?
Lack Of Processing Controls
Which agency issued this recall?
This recall was issued by the FDA Drug on March 18, 2020. Severity: Moderate. Recall number: D-1007-2020.